Division (vii) In the case of studies in which dosing extends over a period, dosing shall preferably be done using a single batch of the micro-organism, if stability permits.F1
United Kingdom
If the studies are not performed using a single batch of the micro-organism, the similarity of the different batches has to be stated.
Whenever a study implies the use of different doses, the relationship between dose and adverse effect must be reported.
Annotations
Textual amendments
- F1
Repealed (subject to transitional measures in Arts. 3, 4) by Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market Text with EEA relevance.